These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7654886)

  • 41. Review article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease.
    Veerappan SG; O'Morain CA; Daly JS; Ryan BM
    Aliment Pharmacol Ther; 2011 Jun; 33(12):1261-72. PubMed ID: 21521250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cortisone-induced osteoporosis: from physiopathology to treatment].
    Audran M; Basle MF
    Rev Med Interne; 1991; 12(6):458-9, 461-4. PubMed ID: 1792440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. All patients with inflammatory bowel disease should have bone density assessment: con.
    Leslie WD
    Inflamm Bowel Dis; 2001 May; 7(2):163-7; discussion 168-9. PubMed ID: 11383590
    [No Abstract]   [Full Text] [Related]  

  • 44. Secondary osteoporosis.
    Reid DM; Harvie J
    Baillieres Clin Endocrinol Metab; 1997 Apr; 11(1):83-99. PubMed ID: 9222487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
    Smith MD; Cheah SP; Taylor K; Ahern MJ
    J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Osteopenia and osteoporosis in inflammatory bowel disease].
    Garcia-Planella E; Domènech E
    Gastroenterol Hepatol; 2004; 27(7):417-24. PubMed ID: 15461942
    [No Abstract]   [Full Text] [Related]  

  • 48. Detection of osteoporosis in patients with inflammatory bowel disease.
    Compston JE
    Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):931-3. PubMed ID: 9391779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Etiopathogenesis, diagnostics and treatment of osteoporosis at inflammatory bowel diseases].
    Eksp Klin Gastroenterol; 2005; (3):8-14, 100. PubMed ID: 16255547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors and management of osteoporosis in inflammatory bowel disease.
    Targownik LE; Bernstein CN; Leslie WD
    Curr Opin Gastroenterol; 2014 Mar; 30(2):168-74. PubMed ID: 24419292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease.
    Clements D; Compston JE; Evans WD; Rhodes J
    Gut; 1993 Nov; 34(11):1543-6. PubMed ID: 8244141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A 2008 panorama on osteoporosis and inflammatory bowel disease.
    Sapone N; Pellicano R; Simondi D; Sguazzini C; Reggiani S; Terzi E; Rizzetto M; Astegiano M
    Minerva Med; 2008 Feb; 99(1):65-71. PubMed ID: 18299697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Corticosteroid-induced osteoporosis.
    Adachi JD
    Int J Fertil Womens Med; 2001; 46(4):190-205. PubMed ID: 11563829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Corticosteroid-induced osteoporosis].
    Trombetti A; Pennisi P; Rizzoli R
    Rev Prat; 2004 Dec; 54(19):2132-7. PubMed ID: 15724591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatments for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis.
    Dear KL; Compston JE; Hunter JO
    Clin Nutr; 2001 Dec; 20(6):541-6. PubMed ID: 11884003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria.
    Kornbluth A; Hayes M; Feldman S; Hunt M; Fried-Boxt E; Lichtiger S; Legnani P; George J; Young J
    Am J Gastroenterol; 2006 Jul; 101(7):1546-50. PubMed ID: 16863559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Iatrogenic demineralizing osteopathies].
    Audran M
    Presse Med; 1994 Feb; 23(6):271-3. PubMed ID: 8208675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Corticosteroid-Induced osteoporosis: detection and management.
    Adachi JD; Papaioannou A
    Drug Saf; 2001; 24(8):607-24. PubMed ID: 11480493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Corticosteroid-induced osteoporosis.
    Lucasey B
    Nurs Clin North Am; 2001 Sep; 36(3):455-66, ix. PubMed ID: 11532660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.